Clinical trials
Completed Phase 2 trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
3,171 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 13 |
| 2001 | 37 |
| 2002 | 50 |
| 2003 | 70 |
| 2004 | 86 |
| 2005 | 116 |
| 2006 | 138 |
| 2007 | 186 |
| 2008 | 181 |
| 2009 | 203 |
| 2010 | 212 |
| 2011 | 213 |
| 2012 | 183 |
| 2013 | 143 |
| 2014 | 144 |
| 2015 | 162 |
| 2016 | 158 |
| 2017 | 153 |
| 2018 | 152 |
| 2019 | 123 |
| 2020 | 108 |
| 2021 | 111 |
| 2022 | 80 |
| 2023 | 62 |
| 2024 | 35 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3,171 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 216 |
| GlaxoSmithKline | 179 |
| Bayer | 102 |
| Boehringer Ingelheim | 98 |
| Hoffmann-La Roche | 98 |
| Pfizer | 88 |
| AstraZeneca | 86 |
| Eli Lilly and Company | 72 |
| Bristol-Myers Squibb | 67 |
| Sanofi | 63 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 105 |
| Carcinoma, Non-Small-Cell Lung | 99 |
| Asthma | 98 |
| Pulmonary Disease, Chronic Obstructive | 81 |
| Diabetes Mellitus, Type 2 | 79 |
| Arthritis, Rheumatoid | 63 |
| Neoplasms | 62 |
| Dermatitis, Atopic | 50 |
| Leukemia, Myeloid, Acute | 46 |
| Psoriasis | 45 |
Trials
Showing 1 to 25 of 3,171. Each trial links to its page on Pharma Observatory.
3,071 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.